Stay updated on Nalbuphine ER in IPF for Cough Clinical Trial
Sign up to get notified when there's something new on the Nalbuphine ER in IPF for Cough Clinical Trial page.

Latest updates to the Nalbuphine ER in IPF for Cough Clinical Trial page
- Check2 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.SummaryDifference0.9%
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.7%
- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated to include new results from a clinical study on Nalbuphine ER tablets for treating cough in patients with Idiopathic Pulmonary Fibrosis (IPF), detailing the study's design, participant dosing, and assessment methods. Additionally, the number of study locations has been revised from 15 to 11.SummaryDifference100%
- Check38 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check52 days agoChange DetectedThe page now indicates that results have been submitted, replacing the previous message that no results were posted.SummaryDifference0.1%
- Check66 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
Stay in the know with updates to Nalbuphine ER in IPF for Cough Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nalbuphine ER in IPF for Cough Clinical Trial page.